• HSBC

Ithmar Capital strengthens healthcare investment platform

  • United Arab Emirates: Tuesday, November 06 - 2007 at 08:10
  • PRESS RELEASE

Ithmar Capital, one of the GCC's leading private equity firms, is to strengthen its investment in the region's healthcare sector with plans for a Cardiovascular Surgery Centre of Excellence in Dubai to be operated by its Fund I portfolio company Belhoul Lifecare.

The Centre of Excellence will operate with surgical, medical and nursing teams from London's world-renowned Harefield Specialist Heart and Lung Hospital, which is part of the Royal Brompton & Harefield NHS Trust and a research partner with the UK's National Heart & Lung Institute.

"This initiative reflects Belhoul Lifecare's vision of becoming a leader in quality healthcare services in the UAE and its commitment to bringing the best level of healthcare to patients in the region. Specialist cardiovascular and thoracic surgery teams will rotate between Dubai and the UK on a continuous basis," said Faisal Belhoul, Vice Chairman, Belhoul Lifecare and Founder and Managing Partner of Ithmar Capital.

The centre will be led by renowned UK-based Cardiac Surgeon Mr. Mohammed Amrani - a world expert in minimally invasive valve and coronary surgery with a special interest in re-do surgery and complex cases. He is an active member of the lung and heart transplant and ventricular assist device programme and has operated on many patients from the UAE, particularly those with complex cardiac conditions. The centre will specialise in all aspects of cardiac surgery, including transplants and minimally invasive procedures.

"We have treated many patients from the region and have always believed in bringing care closer to them. Belhoul Lifecare was the preferred partner for us given its in-depth knowledge and strong track record in healthcare in the UAE. In association with Belhoul Lifecare we will perform the first minimally invasive valve and coronary surgery in the region," explained Amrani.

The Centre of Excellence team work and teach internationally and publish research papers which set international medical standards.

"This expertise can now be accessed at a much more affordable cost by patients in this region, without the addition of UK travel and hotel stay expense. Another benefit is that recovery is typically much quicker when patients are in their home environment," said Dr. Maher Hilali, Belhoul Lifecare Medical Director; who is also a founding member and former vice chairman of the British Arab Medical Association.

Belhoul Lifecare's growth strategy also allows for facility expansion through new-build or improved space utilization.

"Following its investment in the Cardiovascular Centre of Excellence, Belhoul Lifecare plans to establish similar world-class medical centres for diabetes, plastic surgery and oncology, as part of its plan to invest AED 1 billion over the next three years to create a comprehensive healthcare network in the UAE,"


added Belhoul.

Industry studies indicate that the future population growth within the GCC and most particularly the UAE, which is to experience a compound annual growth rate of 2.27% up to the year 2015, will spur demand for first-class medical services.

"Belhoul Lifecare will serve as a healthcare platform which will strategically acquire, merge, establish and collectively manage hospitals, clinics and diagnostic facilities,"explained Khaled Wasfi Jaouni, Board Member, Belhoul Lifecare and Partner at Ithmar Capital. "The aim is to develop a fully integrated network with sufficient linkages to clinical systems, clinical operations and healthcare management expertise; and with the ability to attract and retain highly qualified physicians and practitioners."
 
Article Options
Log in to request more information from Ithmar Capital

Notes and Media Contacts »

For further information please contact:

Maha Masri, IR & Marketing Director, Ithmar Capital Tel: +971 4 282 5555

OR

Tariq Zuroub, MCS/Action, Email: , Tel: + 971 50 2035678

About Ithmar Capital:

Ithmar Capital is a GCC focused private equity specialist, managed by a highly experienced team of focused leaders, with local and international expertise and connectivity.

From its offices in Dubai and London, Ithmar Capital targets exceptional growth capital and buyout opportunities throughout the GCC region and overseas, provided the GCC region represents a strategic market for the overseas companies.

Ithmar Capital is actively committed to using its unrivalled resources and international connectivity to strongly support the success of its portfolio companies.

With a focus on innovation, Ithmar Capital is at the cutting edge of its industry, always looking at new ways of adding value to its partners and portfolio companies.

Ithmar Capital is the first regional private equity specialist that has entered into a strategic alliance with global private equity leader - 3i. The partnership combines local and regional knowledge and network with true global reach and expertise.

Ithmar Capital is currently managing proprietary investments in excess of $500m in some of the most attractive sectors in the region such as oil and gas, construction, healthcare and education.

Ithmar Capital's vision is to be the leading regional private equity firm in terms of conduct and return.

About Belhoul Lifecare:

One of the Ithmar Capital Fund I portfolio companies, Belhoul Lifecare was established as a platform for consolidating healthcare growth comprising hospitals and clinics across the GCC. The company currently comprises Belhoul Specialist Hospital, a 60-bed tertiary care hospital providing advanced diagnostic, interventional and therapeutic facilities and Belhoul European Hospital, one of the most well-reputed hospitals in the UAE's private sector. Belhoul European Hospital is the most well-established specialist day-care hospitals in the UAE with the most advanced facilities for short-stay surgeries and procedures.

Belhoul Lifecare's growth strategy is centered around creating a fully intergrated healthcare services network in the UAE through mergers, acquisitions and new projects.

Disclaimer »

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions